NCT04496830View on ClinicalTrials.gov

SPINCOMS Biomarker Study

CompletedOBSERVATIONAL
Enrollment

161

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

November 24, 2023

Study Completion Date

November 24, 2023

Conditions
Multiple Sclerosis
Trial Locations (1)

63110

Washington University in St Louis, St Louis

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Ottawa

OTHER

collaborator

Montana State University

OTHER

lead

Washington University School of Medicine

OTHER

NCT04496830 - SPINCOMS Biomarker Study | Biotech Hunter | Biotech Hunter